BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 8779688)

  • 1. Allogeneic class I MHC requirement for alloantigen-reactive helper T-lymphocyte responses in vivo. Evidence for indirect presentation of alloantigen.
    Clement JD; Chan SY; Bishop DK
    Transplantation; 1996 Aug; 62(3):388-96. PubMed ID: 8779688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative Frequencies of Alloantigen-Specific Helper CD4 T Cells and B Cells Determine Mode of Antibody-Mediated Allograft Rejection.
    Alsughayyir J; Chhabra M; Qureshi MS; Mallik M; Ali JM; Gamper I; Moseley EL; Peacock S; Kosmoliaptsis V; Goddard MJ; Linterman MA; Motallebzadeh R; Pettigrew GJ
    Front Immunol; 2018; 9():3039. PubMed ID: 30740108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of graft-versus-host disease (GVHD) and graft rejection using MHC class I-deficient mice.
    Shenoy S; Desch K; Duffy B; Thorson P; Mohanakumar T
    Clin Exp Immunol; 1998 May; 112(2):188-95. PubMed ID: 9649180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior viral infection primes cross-reactive CD8+ T cells that respond to mouse heart allografts.
    Khorki ME; Shi T; Cianciolo EE; Burg AR; Chukwuma PC; Picarsic JL; Morrice MK; Woodle ES; Maltzman JS; Ferguson A; Katz JD; Baker BM; Hildeman DA
    Front Immunol; 2023; 14():1287546. PubMed ID: 38143762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of human CD4 helper T cell responses against Aurora kinase A.
    Kobayashi H; Azumi M; Hayashi S; Sato K; Aoki N; Kimura S; Kakizaki H; Nagato T; Harabuchi Y; Tateno M; Celis E
    Cancer Immunol Immunother; 2010 Jul; 59(7):1029-39. PubMed ID: 20182874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inverted direct allorecognition triggers early donor-specific antibody responses after transplantation.
    Charmetant X; Chen CC; Hamada S; Goncalves D; Saison C; Rabeyrin M; Rabant M; Duong van Huyen JP; Koenig A; Mathias V; Barba T; Lacaille F; le Pavec J; Brugière O; Taupin JL; Chalabreysse L; Mornex JF; Couzi L; Graff-Dubois S; Jeger-Madiot R; Tran-Dinh A; Mordant P; Paidassi H; Defrance T; Morelon E; Badet L; Nicoletti A; Dubois V; Thaunat O
    Sci Transl Med; 2022 Sep; 14(663):eabg1046. PubMed ID: 36130013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression.
    Merola J; Reschke M; Pierce RW; Qin L; Spindler S; Baltazar T; Manes TD; Lopez-Giraldez F; Li G; Bracaglia LG; Xie C; Kirkiles-Smith N; Saltzman WM; Tietjen GT; Tellides G; Pober JS
    JCI Insight; 2019 Oct; 4(20):. PubMed ID: 31527312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyclonally Derived Alloantigen-Specific T Regulatory Cells Exhibit Target-Specific Suppression and Capture MHC Class II from Dendritic Cells.
    Oya Y; Tanaka Y; Nakazawa T; Matsumura R; Glass DD; Nakajima H; Shevach EM
    J Immunol; 2024 Jun; 212(12):1891-1903. PubMed ID: 38683146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional reprogramming of mature CD4⁺ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes.
    Mucida D; Husain MM; Muroi S; van Wijk F; Shinnakasu R; Naoe Y; Reis BS; Huang Y; Lambolez F; Docherty M; Attinger A; Shui JW; Kim G; Lena CJ; Sakaguchi S; Miyamoto C; Wang P; Atarashi K; Park Y; Nakayama T; Honda K; Ellmeier W; Kronenberg M; Taniuchi I; Cheroutre H
    Nat Immunol; 2013 Mar; 14(3):281-9. PubMed ID: 23334788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of alloimmune Th1 responses by the cyclin-dependent kinase inhibitor p21 following transplantation.
    Welling TH; Lu G; Csencsits K; Wood SC; Jarvinen L; Bishop DK
    Surgery; 2008 Mar; 143(3):394-403. PubMed ID: 18291261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lethal host-versus-graft disease and hypereosinophilia in the absence of MHC I-T-cell interactions.
    Coudert JD; Foucras G; Demur C; Coureau C; Mazerolles C; Delsol G; Druet P; Guéry JC
    J Clin Invest; 2000 Apr; 105(8):1125-32. PubMed ID: 10772657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways of Antigen Recognition by T Cells in Allograft Rejection.
    Carnel N; Lancia HH; Guinier C; Benichou G
    Transplantation; 2023 Apr; 107(4):827-837. PubMed ID: 36398330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Draining lymph nodes of corneal transplant hosts exhibit evidence for donor major histocompatibility complex (MHC) class II-positive dendritic cells derived from MHC class II-negative grafts.
    Liu Y; Hamrah P; Zhang Q; Taylor AW; Dana MR
    J Exp Med; 2002 Jan; 195(2):259-68. PubMed ID: 11805152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection.
    McIntosh CM; Allocco JB; Wang P; McKeague ML; Cassano A; Wang Y; Xie SZ; Hynes G; Mora-Cartín R; Abbondanza D; Chen L; Sattar H; Yin D; Zhang ZJ; Chong AS; Alegre ML
    J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37676735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of helper T cells for induction of tumour rejection by cytolytic T lymphocytes.
    Stuhler G; Walden P
    Cancer Immunol Immunother; 1994 Nov; 39(5):342-5. PubMed ID: 7987867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell antigenicity and immunogenicity of allogeneic exosomes.
    Prunevieille A; Babiker-Mohamed MH; Aslami C; Gonzalez-Nolasco B; Mooney N; Benichou G
    Am J Transplant; 2021 Jul; 21(7):2583-2589. PubMed ID: 33794063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire.
    Bonilla WV; Geuking MB; Aichele P; Ludewig B; Hengartner H; Zinkernagel RM
    J Clin Invest; 2006 Jan; 116(1):156-62. PubMed ID: 16395404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host defense against Mycobacterium avium does not have an absolute requirement for major histocompatibility complex class I-restricted T cells.
    Bermudez LE; Petrofsky M
    Infect Immun; 1999 Jun; 67(6):3108-11. PubMed ID: 10338527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the Benefits and Drawbacks of Stem Cell Therapy Based on the Cell Origin or Manipulation Process: Addressing Immunogenicity.
    Chang SH; Park CG
    Immune Netw; 2023 Dec; 23(6):e44. PubMed ID: 38188600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting mRNA-encoded interleukin-2 restores CD8
    Beck JD; Diken M; Suchan M; Streuber M; Diken E; Kolb L; Allnoch L; Vascotto F; Peters D; Beißert T; Akilli-Öztürk Ö; Türeci Ö; Kreiter S; Vormehr M; Sahin U
    Cancer Cell; 2024 Apr; 42(4):568-582.e11. PubMed ID: 38490213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.